Sign in

CIK 0001935979

  • Large accelerated filer

Biohaven Ltd.

Sign in to watch
Ticker
BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Virgin Islands, British
Entity type
Operating
Phone
+1 203-404-0410
Business address
215 CHURCH STREET, NEW HAVEN, CT, 06510
Former names
Biohaven Research Ltd.
  1. 4 Open-market buy Director bought 29,000 shares at $35.94 ($1,042,393)
  2. 4 Open-market buy Director bought 21,052 shares at $47.50 ($999,970)
  3. 4 Open-market buy Chief Executive Officer bought 21,052 shares at $47.50 ($999,970)
  4. 4 Open-market buy Director bought 5,000 shares at $44.19 ($220,966)
  5. 4 Open-market buy Director bought 28,400 shares at $35.67 ($1,012,983)
  6. 4 Open-market buy Chief Scientific Officer bought 30,000 shares at $33.58 ($1,007,490)
  7. 4 Open-market buy Director bought 28,000 shares at $35.58 ($996,240)
  8. 4 Open-market buy Director bought 15,000 shares at $34.19 ($512,877)
  9. 4 Open-market buy Director bought 28,500 shares at $35.17 ($1,002,470)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 25,503 shares at $39.18 ($999,169)
  18. 4 Open-market buy Director bought 48,780 shares at $41.00 ($1,999,980)
  19. 4 Open-market buy Director bought 195,121 shares at $41.00 ($7,999,961)
  20. 4 Open-market buy Chief Executive Officer bought 121,951 shares at $41.00 ($4,999,991)

Page 3 of 7 · 130 filings